This would imply that heterozygous ABCC6 mutations are an important risk factor for the development of ischemic stroke, which would have important implications for the counseling and management of PXE and cryptogenic stroke families. The gene discussed is ABCC6; the disease is pseudoxanthoma elasticum (inherited or acquired).